Identification of the Upregulation of MRPL13 as a Novel Prognostic Marker Associated with Overall Survival Time and Immunotherapy Response in Breast Cancer

<div>Constructing and evaluating the nomogram for MRPL13. (a) Univariate analysis and (b) multivariate analysis of the correlation between MRPL13 and overall survival in BRCA. (c) The nomogram is constructed for MRPL13 in BRCA. (d) Calibration curves of the nomogram for the prediction of survival rates at 1, 3, and 5 years.</div>

Computational and Mathematical Methods in Medicine

fig2

Figure 2

Figure 2: Identification of the Upregulation of MRPL13 as a Novel Prognostic Marker Associated with Overall Survival Time and Immunotherapy Response in Breast Cancer 

Figure 2 | Identification of the Upregulation of MRPL13 as a Novel Prognostic Marker Associated with Overall Survival Time and Immunotherapy Response in Breast Cancer 